Search Results - "Babović, N."

PO-075: Treatment of nasopharyngeal cancer: a Serbian institututinal experience by Ursulovic, T, Babovic, N

Get full text

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries by Kandolf Sekulovic, L., Guo, J., Agarwala, S., Hauschild, A., McArthur, G., Cinat, G., Wainstein, A., Caglevic, C., Lorigan, P., Gogas, H., Alvarez, M., Duncombe, R., Lebbe, C., Peris, K., Rutkowski, P., Stratigos, A., Forsea, A.-M., De La Cruz Merino, L., Kukushkina, M., Dummer, R., Hoeller, C., Gorry, C., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Arenberger, P., Bylaite-Bucinskiene, M., Babovic, N., Banjin, M., Putnik, K., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Ymeri, A., Stojkovski, I., Garbe, C.

“…According to data from recent studies from Europe, a large percentage of patients have restricted access to innovative medicines for metastatic melanoma…”
Get full text

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments by Kandolf Sekulovic, L, Peris, K, Hauschild, A, Stratigos, A, Grob, J.-J, Nathan, P, Dummer, R, Forsea, A.-M, Hoeller, C, Gogas, H, Demidov, L, Lebbe, C, Blank, C, Olah, J, Bastholt, L, Herceg, D, Neyns, B, Vieira, R, Hansson, J, Rutkowski, P, Krajsova, I, Bylaite-Bucinskiene, M, Zalaudek, I, Maric-Brozic, J, Babovic, N, Banjin, M, Putnik, K, Weinlich, G, Todorovic, V, Kirov, K, Ocvirk, J, Zhukavets, A, Kukushkina, M, De La Cruz Merino, L, Ymeri, A, Risteski, M, Garbe, C

“…Abstract Background Despite the efficacy of innovative treatments for metastatic melanoma, their high costs has led to disparities in cancer care among…”
Get full text

1102 In Vitro Enhancement of NK Cell Activity of Metastatic Melanoma Patients With IFN-alpha Alone as Opposed to its Combination With 13-cis Retinoic Acid is Associated With Modulation of NKG2D and CD161 Activating Receptor Expression by Konjevic, G, Mirjacic-Martinovic, K, Vuletic, A, Babovic, N

Get full text

Phase II trial of pirfenidone in adults with neurofibromatosis type 1 by BABOVIC-VUKSANOVIC, D, BALLMAN, K, SPINNER, R, O'NEILL, B, MICHELS, V, MCGRANN, P, LINDOR, N, KING, B, CAMP, J, MICIC, V, BABOVIC, N, CARRERO, X

“…We performed an open-label phase II trial of oral pirfenidone in 24 patients with neurofibromatosis type 1 (NF1). Tumors were monitored by three-dimensional…”
Get full text

In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-α alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression by Konjevic, G, Mirjacic-Martinovic, K, Vuletic, A, Babovic, N

“…Considering tumor-induced suppression of natural killer (NK) cell activity the aim of this study was to investigate the in vitro effect of a standard…”
Get more information

Serum gonadotropin levels in patients with germ-cell tumors of the testis: interrelations, possible cross-reactions and interpretation of beta-HCG level by Kovcin, V N, Jelić, S B, Ivanović, S M, Babović, N L

“…The concentration of FSH, LH, LTH, testosterone and beta-hCG was estimated in 177 serum samples from 86 patients with malignant germ-cell tumors of the testis…”
Get more information

302 The effect of differential in vitro regulation of NKG2D and CD161 NK cell receptors by IL-2 or IFN-a on activation of NK cells in metastatic melanoma patients by Konjevic, G, Mirjacic Martinovic, K, Vuletic, A, Babovic, N

Get full text

Epirubicin 150 mg/m2-cisplatin versus epirubicin 180 mg/m2-cisplatin for advanced soft tissue sarcoma by Jelić, S, Babović, N, Kreacić, M, Matković, S, Milanović, N, Gavrilović, D, Tomasević, Z

“…We have previously reported the superiority of the epirubicin 180 mg/m2-cisplatin combination over single drug epirubicin 180 mg/m2 for advanced soft tissue…”
Get more information

Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy? by Babovic, N, Jelic, S, Jovanovic, V

“…Primary lymphoma of the breast is a rare disease that has been estimated to represent from 0.05% to 0.53% of all malignant breast tumors and approximately 2.2%…”
Get more information

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study by Jelić, Svetislav, Mitrović, Labuda, Radosavljević, Davorin, Elezar, Elizabeta, Babović, Nada, Kovčin, Vladimir, Tomašević, Zoran, Kovačević, Svetlana, Gavrilović, Dušica, Radulović, Siniša

“…This communication represents the definitive report of a randomized phase III study comparing cisplatin and carboplatin, in combination with vindesine and…”
Get full text

Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma by JELIC, S, KOVCIN, V, MILANOVIC, N, BABOVIC, N, KREACIC, M, RISTOVIC, Z, VLAJIC, M, FILIPOVIC-LJESKOVIC, I

“…A randomised study was started in chemotherapy-naive patients with advanced soft tissue sarcomas who received either epirubicin 60 mg/m 2/24 h (total dose for…”
Get full text

1054 The existence of humoral immunity to gliadin and cow's milk proteins in patients with prostatic diseases by Besu, I, Juranic, Z, Djordjevic, M, Konic-Ristic, A, Filipovic-Ljeskovic, I, Babovic, N, Jelic, S

Get full text

EDTA clearance in monitoring cisplatin dose escalation in patients with bulky metastatic germ cell tumors of the testis by Jelić, S, Kovcin, V, Babović, N, Vuletić, L

“…A fast cisplatin clearance may reduce exposure time of tumor cells to the drug, and thus impair the expected effects of dose escalation. This hypothesis was…”
Get more information

5551 POSTER Impact of Cisplatin potentiation by Cytarabine in the 5-FU-CDDP regimen for dismal-prognosis head and neck cancer (HNC) patients; a meta-analysis of 3 local trials involving 492 patients by Jelic, S, Kreacic, M, Ursulovic, T, Vucicevic, S, Gavrilovic, D, Jovanovic, N, Babovic, N, Petrovic, Z, Mikic, A

Get full text

Use of high-dose cytarabine to enhance cisplatin cytotoxicity—effects on the response and overall survival rates of advanced head and neck cancer patients by JELIC, S, STAMATOVIC, Lj, VUCICEVIC, S, PETROVIC, Z, KREACIC, M, BABOVIC, N, JOVANOVIC, N, MIKIC, A, GAVRILOVIC, D

“…It has been reported that cytarabine, acting by at least two different mechanisms, enhances the cytotoxic effect of cisplatin in in vitro systems. The aim of…”
Get full text

Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study by Jelić, S, Babovic, N, Kovcin, V, Milicevic, N, Milanovic, N, Popov, I, Radosavljevic, D

“…The aim of this randomized four-arm phase III study was to evaluate whether there is a difference in activity between regimens containing dacarbazine and…”
Get full text

Antimelanoma immunity in vitiligo and melanoma patients by Juranic, Z D, Stanojevic-Bakic, N, Zizak, Z, Babovic, N, Radovic-Kovacevic, V, Stanojkovic, T, Dzodic, R

“…Cutaneous melanoma and vitiligo are diseases etiology of which evolves around melanocytes. The nature of immunological disturbances associated with these…”
Get more information

Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures: a single-center study by Jelić, S, Babović, N, Stamatović, L, Kreacić, M, Matković, S, Popov, I

“…First-line treatments of metastatic melanoma are usually decarbazine (DTIC) and/or alpha-interferon based, with response rates in the range of at most 20-30%…”
Get full text

Pilot study of daily ifosfamide 1 g/m2 until grade III granulocytopenia as second-line chemotherapy for anthracycline-pretreated advanced soft tissue sarcoma by Babović, N, Jelić, S, Milanović, N, Matković, S

“…Second-line chemotherapy regimens for advanced soft tissue sarcomas after treatment failure or tumor relapse following anthracyclines are still…”
Get more information